Liberato 3 , Sonya Eremenco 1 1 Critical Path Institute, Tucson, Arizona, USA, 2 Evidera, Wilmington, North Carolina, USA, 3 Evidera, London, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :1002 Aims Based on emerging technologies enabling data collection via mobile sensor devices (e.g., activity monitors), there is increasing interest in leveraging them to collect clinical trial endpoint data in persons with chronic heart failure (CHF)
GLP-1 agonists are FDA-approved drugs used to help lower blood sugar in people with type 2 diabetes
Fast Dispatch We aim to dispatch all orders quickly, securely, and discreetly from our UK and Ireland distribution facilities
The FDA approval of the first oral GLP-1 for weight loss in December 2025-Novo Nordisk's once-daily semaglutide pill-represents a watershed moment for the category [3]
If youre switching medications, you may not be able to jump right into taking your previous dose
Its also important to have realistic expectations